Skip to main content
Watch Insiders
PALIHealthcare

Palisade Bio Inc (PALI) Insider Trading

In the last 90 days, 1 Palisade Bio Inc (PALI) insider reported 1 open-market purchase totaling $28,800 and no sales. The most recent open-market purchase was reported on Oct 2, 2026. Source: SEC Form 4 filings.

SEC-reported filing activity is provided for research purposes and is not investment advice.

90-day C-suite buyers
0
90-day purchase value
$28,800
Corporate buyers
1
Latest transaction
Oct 2, 2026

Executive filings

Open-market transaction history

Purchase and sale summaries are ordered by the latest reported transaction date.

Open-market insider purchase and sale transactions
DateInsider nameRoleTypeSharesPriceTotal value
Oct 2, 2026Donald Allen WilliamsCorporate insiderOpen Market Purchase20,000$1.44$28,800
Jul 9, 2026Robert Baltera Jr.Corporate insiderOpen Market Purchase45,000$1.97$88,700
Jul 7, 2026Robert Baltera Jr.Corporate insiderOpen Market Purchase50,000$2.04$102,085
Jul 7, 2026Mitchell Lawrence JonesChief Medical OfficerSale51,880$2.05$106,536
Jul 7, 2026John David FinleyCEO, CFOSale146,798$2.07$303,343
Jul 2, 2026Robert Baltera Jr.Corporate insiderOpen Market Purchase30,000$1.98$59,400

Common questions

PALI insider trading FAQ

Are PALI insiders buying or selling?
Over the last 90 days, PALI insiders were net buyers, reporting $28,800 of open-market purchases and $0.00 of sales.
When was the last PALI insider purchase?
The most recent open-market purchase of Palisade Bio Inc stock by an insider was reported on Oct 2, 2026, one of 1 purchase in the last 90 days.
Where does PALI insider trading data come from?
Watch Insiders reads the SEC Form 4 filings that Palisade Bio Inc officers, directors, and 10% owners submit to EDGAR, and refreshes this page daily.